TrialJAMA oncology2018

Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas: A Phase 2 Clinical Trial.

Maud Toulmonde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.